The Conferences
In 2025, the PharmaLab Congress will again offer a diverse programme to professionals from analytical and microbiological quality control in industry, from contract laboratories, authorities and service providers.
The congress, which is aimed at employees and managers in all laboratory areas of the pharmaceutical industry, is composed of a pre-conference workshop, international conferences from the fields of analytics, bioanalytics, microbiology and CGT/ATMP, as well as the accompanying exhibition.
Speakers will provide information on the latest developments in laboratory methods, systems, materials and the current status of regulatory requirements of pharmacopoeias and guidelines in their lectures.
Two pre-conference workshops on 24 November and several conferences on 25/26 November 2025 will provide delegates with important and new information on analytics, bioanalytics and microbiology. You can find more information about the individual conferences by clicking on the following links:
- GMP Compliance Trends Analytical Laboratories
- NEW! Analytical Quality and Lifecycle Concepts
- Laboratory Optimization, Automation and Digitalization
- NEW! Artificial Intelligence in Laboratories
- Endotoxin and Pyrogen Testing
- Alternative and Rapid Microbiological Methods
- Cell and Gene Therapies/ ATMPs - Quality and Safety
- Bioassays/Potency Assays – Regulatory Requirements, Development and Routine Use
- NEW! Bioanalytical Control of Biological Drug Substances and Products
Two PharmaLab Pre-Conference Workshops on 24 November 2025:
- 6th International Mycoplasma qPCR Testing User Day (Track QC Microbiology)
- NEW! Quality Control for mRNA/LNP Products
One-day and multi-day tickets offered the opportunity to attend parts or even the entire congress and thereby put together an own individual programme with the lectures of the delegates' choice.
Register for the congress as a delegate now:
KEYNOTE 25 November 2025
Artificial AI in Pharma: The Hype, The Hope, The How
Dr Marcel Franke, Senior Scientist Predictive Formulation,Process Solutions/Upstream & Process Materials R&D, Merck Life Science
- The Hype – Big Budgets, Bigger Promises
- The Hope – A Shift from Trend to Transformation
- The How – data Integrity, Human and Organizaional Readiness and Regulatory Enablement
KEYNOTE 26 November 2025
Phage Therapy: History, Current Challenges and Perspectives
Dr Frédérique Vieville, CEO, 5QBD-Biotech
- From history to today – rediscovering phage therapy in the context of modern medicine
- Antimicrobial resistance – why phages are part of the answer
- Challenges: scientific, CMC, regulatory
- What lies ahead – opportunities and pathways for integration into healthcare